Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming - Quiz - MDSpire

Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming

  • By

  • Zhan Wang

  • Zhaokai Zhou

  • Shuai Yang

  • Zihao Zhao

  • Xiaozu Li

  • Xingchen Liu

  • Guangyang Cheng

  • Ran Xu

  • Qi Li

  • Dong Xing

  • June 30, 2026

  • 0 min

Share

Original Source(s)

Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming

  • by Zhan Wang, Zhaokai Zhou, Shuai Yang, Zihao Zhao, Xiaozu Li, Xingchen Liu, Guangyang Cheng, Ran Xu, Qi Li, Dong Xing

  • June 30, 2026

Related Content

The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study

Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report

CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis

A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice

  • June 30, 2026

  • 3 min